McCarron M A, Kutlaca A, Morley A A
Department of Haematology, Flinders Medical Centre, Bedford Park, South Australia.
Mutat Res. 1989 Apr;225(4):189-93. doi: 10.1016/0165-7992(89)90118-8.
The HLA-A assay for detection of mutant lymphocytes has been modified, principally by incorporation of an overnight-incubation step which has resulted in improved immunoselection. For 83 estimations on cells from 21 normal individuals with a mean age of 35, the in vivo mutant frequency was 2.99 X 10(-5) +/- 1.48 X 10(-5) (mean +/- 1 SD). For 11 estimations on cells from 10 elderly individuals with a mean age of 78, the mutant frequency was significantly greater, being 7.16 X 10(-5) +/- 4.06 X 10(-5). Similar results were obtained when HLA-A2 or HLA-A3 mutants were enumerated. Mutant frequency measured at the HLA-A locus is almost an order of magnitude greater than that measured at the hypoxanthine phosphoribosyl transferase locus, but at least the major part of this difference is likely to be due to factors other than a difference in genetic stability between the two loci.
用于检测突变淋巴细胞的HLA - A检测方法已得到改进,主要是加入了过夜孵育步骤,这使得免疫选择得到了改善。对21名平均年龄为35岁的正常个体的细胞进行了83次检测,体内突变频率为2.99×10(-5)±1.48×10(-5)(平均值±1标准差)。对10名平均年龄为78岁的老年人的细胞进行了11次检测,突变频率显著更高,为7.16×10(-5)±4.06×10(-5)。对HLA - A2或HLA - A3突变体进行计数时也得到了类似结果。在HLA - A位点测得的突变频率比在次黄嘌呤磷酸核糖转移酶位点测得的突变频率几乎高一个数量级,但至少这种差异的主要部分可能是由于两个位点之间遗传稳定性差异以外的因素造成的。